WOUNDTEK, INC ANNOUNCES TWO NEW MEMBERS OF ITS BOARD OF DIRECTORS: INDUSTRY VETERANS WITH A TRACK RECORD OF SUCCESS JOIN THE TEAM

NEWPORT, RI, December 22, 2005 – WoundTEK, Inc., a privately held medical device company, announced today that has recruited two new members to its Board of Directors. Helping to round out a strong leadership team for future growth of the company and its expanding operations.
David LaSalle, founder and Managing Director of Apex Surgical (recently sold to Omni Life Sciences, Inc.), has joined the Board along with James Lousararian, Founder and Chief Executive Officer of Angiolink, Corp.(sold to Medtronic, Inc. [MDT:NYSE] in 2004)

"We are very happy to welcome both David LaSalle and Jim Lousaraian to our management team. Both have great track records for growing successful medical device businesses during tough economic times. Each brings unique skill sets to bear that will help us grow our company rapidly and successfully over the years to come.” Said Andrew Reilly, WoundTEK, Inc. Chief Executive.

“WoundTEK, Inc. which grew over 200% in revenues in 2005 is poised to become a leader in the wound closure market space. I am delighted to be part of such a strong team and behind such a great product “ said Jim Lousaraian. He added “ As WoundTEK increases its awareness of the S.T.A.R. device through a growing distribution channel the company solidifies its place in the wound care market as a innovative leader”.

David LaSalle said, “ The STAR device is being so well received in the market that it makes being a part of the management team an exciting and exhilarating place to be. Our challenges ahead will be to manage company growth and market demand for WoundTEK’s product and to balance all of the moving parts of the business through this rapid growth stage”.

WoundTEK, Inc based in Newport, RI is a medical device company focused on the closure of large wounds and skin deficits caused by trauma or surgery. The company manufactures The S.T.A.R. Device. The first minimally invasive tissue expansion device, The S.T.A.R. rapidly closes large open wounds that cannot be closed using primary closure methods. The S.T.A.R. is a simple, effective and proven method of closing large wounds, chronic wounds, and skin deficits. Comprised of a winder reel and an anchor mechanism joined by a simple mattress suture, The S.T.A.R. is able to rapidly expand tissue across large skin deficits with very little discomfort, closing large wounds faster and raising the level of patient care.

Large wound closure is a major health care problem worldwide and is one of the leading causes of deadly infections in the United States. Almost 2,00,000 trauma cases and surgical procedures each year are faced with the challenge of closing large wounds and skin deficits. Current procedures to close large wounds can be technically demanding, increase the risk of infection, and be very invasive, painful, and have deep scaring effects to the tissue. The S.T.A.R. System reduces many of the challenges that are currently faced by surgeons today.

# # #

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which WoundTEK operates; unanticipated manufacturing disruptions, delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.